Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Vanta Bioscience Ltd

Vanta Bioscience | 540729

Market Closed
₹18.00
₹0.50 (-2.70%)
As on 23/11/26, 2:16 AM
Market Cap--- CR
Current Price₹---
High / Low₹--- / ---
PE Ratio0
Book Value₹16.51
Dividend Yield0.00%
ROCE0.00%
ROE0.00%
Face Value₹2.00
Current Vol.---
Average Vol.---
ISININE695X01011
PB Ratio1.34
Debt to Equity5.11
Net Profit Margin-678.06
Operating Margin-211.22

- Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹18.5₹18
₹18
Previous CloseToday's Open
₹14.71₹25.85
₹18
52W Low52W High
₹18Today's Open
₹18.5Previous Close
2,250Volume
₹14.7152W Low
₹25.8552W High

Ratios

No data available

About Company

  • Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017
  • VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries
  • In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product
  • It also provides expert services for determination of health based exposure limits (e
  • permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers
  • The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe
  • One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world
  • Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms
  • It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms
  • The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as 'Vanta Bioscience' (a toxicology division and commenced commercial activities in April, 2017

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSIN/A
SMA 20N/A
SMA 50N/A
SMA 100N/A
SMA 200N/A
SMA 10N/A
MACD_12_26_DaysN/A
EMA10DayN/A
EMA20DayN/A
EMA50DayN/A
MACD_12_26_9_DaysN/A
EMA100DayN/A
EMA200DayN/A

Pivot Points

Volume Analysis
📊

No Information Available

Volume Analysis data is not available at this time.

Growth Rate

Revenue Growth-79.84%
ROE0.00%
EBITDA Margin-211.22%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
1.96
9.72
6.28
9.69
10.04
Interest
4.07
5.75
5.89
2.35
2.14
Expenses
6.22
8.41
8.67
6.22
6.09
Financing Profit
-4.15
1.42
-1.71
3.89
3.98
Financing Margin %
-211%
15%
-27%
40%
40%
Other Income
0.11
0.11
0.69
0.42
0.03
Depreciation
4.42
4.50
2.67
1.32
1.25
Profit before tax
-12.63
-8.83
-10.26
0.23
0.59
Tax %
-5%
2%
-2%
41%
24%
Net Profit
-13.29
-8.61
-10.44
0.13
0.45
EPS in Rs
-7.56
-3.67
-10.27
0.14
0.71
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
30 Sept 2026
AGM
AGM
05 Sept 2026
30 Sept 2025
AGM
AGM
06 Sept 2025
04 Jan 2025
EGM
EGM
07 Dec 2024
30 Sept 2024
AGM
AGM
06 Sept 2024
30 Sept 2023
AGM
AGM
06 Sept 2023
31 Dec 2022
AGM
AGM
08 Dec 2022
31 Dec 2021
AGM
AGM
06 Dec 2021

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
18
13
120
1
26
5
-678.06%
9,190
1,32,139
58
12
42
1
7.94%
1,080
1,05,080
74
9
55
0
17.23%
702
92,366
95
6
53
1
8.87%
780
67,960
123
9
75
1
9.20%
825
62,284
58
6
40
0
11.20%
1,481
39,829
62
9
44
0
12.56%
1,945
39,757
44
8
27
1
10.21%
2,007
33,680
56
12
43
0
18.45%
797
33,483
165
9
57
2
6.20%
Showing 10 of 71 Results

Frequently Asked Questions

What is Share Price of Vanta Bioscience Ltd?

The current share price of Vanta Bioscience Ltd (Vanta Bioscience) is ₹18.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Vanta Bioscience Ltd?

The Price-to-Earnings (P/E) ratio of Vanta Bioscience Ltd is 118.19. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Vanta Bioscience Ltd?

Vanta Bioscience Ltd has a 52-week high of ₹25.85 and a 52-week low of ₹14.71. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Vanta Bioscience Ltd?

Vanta Bioscience Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Vanta Bioscience Ltd?

The Earnings Per Share (EPS) of Vanta Bioscience Ltd is ₹0.15. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Vanta Bioscience Ltd?

Vanta Bioscience Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2